N/A

Markets. We are in a mild deflationary period, and when we get these deflationary shocks, all asset prices spike down and the US$ responds in a very violent upward motion. We had that at the beginning of January/2016. It has been relatively peaceful since mid-February, and the markets are going to be boring until we get another deflationary spike. Had thought Brexit could have been a potential for deflationary spikes. The US election in November could be a spike. Feels the US$ is the place to be.

BUY ON WEAKNESS

The chart is amazing. It closed at $117.76. He has a fair market value of $124.06, a 5.8% upside. However, he wouldn’t buy it here, but would wait for a pullback to $104-$105.

DON'T BUY

Wouldn’t touch this with a 10-foot pole. He was the biggest cheerleader on this company from $50 US all the way up to over $300 Canadian. Had thought Mike Pearson was one of a handful of people who could actually do a rollup correctly. This is a failed rollup, and like all failed rollups, you get a turnaround guy in, who will start selling the crown jewels. There is $30 billion worth of debt, and more importantly there is $18.5 billion of goodwill on the books, which all has to be written off. Predicts this goes considerably lower.

BUY ON WEAKNESS

His model price is $32 giving it an 81% upside. Pays a nice yield of 4.2%. $14 would be a pretty good Buy. It is probably at its current price because of its yield. He would consider this as a weak Hold.

BUY ON WEAKNESS

His model price is $226.98. Current price of $355 is a 35% overvaluation. Would buy this at $228, what he considers its BV. This is often mentioned as one of the systemic risks in this market. There are a lot of redemptions from Sovereign Wealth Funds, etc., and this is where all those assets lie. Be very cautious on this.

BUY ON WEAKNESS

Just sold his holdings. If it got back to $106 again, he would be a buyer. Feels this is really a trading stock, not a buy and hold. His model price is $122.74.

BUY

He likes healthcare. His model price is $163.61, an upside of 9% from the current price of $152. A year from now he feels it is worth $179. 2.7% dividend yield.

COMMENT

The Fed has flip-flopped everywhere on rate hikes, and US financials have flip-flopped with them. US financials are very, very hard, because the Fed doesn’t know what to do. Until there is more clarity he feels financials go nowhere.

PAST TOP PICK

(A Top Pick June 16/15. Down 22.07%.) The market is questioning the balance sheet. It looked like the Fed was ready to move on rates. Feels you should have a bit of this along with Citigroup (C-N) in case things turn around positively. It is hard to recommend it here.

PAST TOP PICK

(A Top Pick June 16/15. Down 28.92%.) A head scratcher for him. His model price is $178, a 116% upside. He still likes it.

PAST TOP PICK

(A Top Pick June 16/15. Down 7.67%.) This is old tech. His model price is $48, and he is showing a 20% upside. If it got down to $33, he would buy more.

BUY ON WEAKNESS

This had a massive write off. In Canada, material stocks have not written off their balance sheets, and he doesn’t know why. His model price is $10.54, but he would wait for a pullback to around $4.

SELL

This went from $3.85 to the current price of $16+. He had been waiting for them to do some write offs. They did a very small one. The stocks are high volatile situations that people seem to be betting on, as opposed to fundamentals. If something should happen to China, this signals all the way back to $3 again.

PARTIAL BUY

The ownership structure is a little under the cloud here, in terms of the original owners at how much stock they own. His model price is $65.44, a 25% upside. Would love this at $42, but $52 is not bad. Pick away at this.

BUY ON WEAKNESS

An entry point on this is $71.50. His model price is $98.80, a 30% upside. Has been waiting for this to come back.